- UBS downgraded Surgery Partners to Neutral from Buy.
- No price target or rationale was disclosed.
UBS cut its rating on Surgery Partners to Neutral from Buy, per a ratings action report. No price target or rationale was given.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.